Advancing use of long‐acting and extended delivery HIV prevention and treatment regimens-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advancing use of long‐acting and extended delivery HIV prevention and treatment regimens

Published:2023-07 Issue:S2 Volume:26 Page:
ISSN:1758-2652
Container-title:Journal of the International AIDS Society
language:en
Short-container-title:J Int AIDS Soc.

Author:

Delany‐Moretlwe Sinéad¹^ORCID,Flexner Charles²,Bauermeister José A.³

Affiliation:

1. Wits Reproductive Health and HIV Institute University of the Witwatersrand Johannesburg South Africa

2. Divisions of Clinical Pharmacology and Infectious Diseases Johns Hopkins University Baltimore Maryland USA

3. Department of Family & Community Health University of Pennsylvania Philadelphia Pennsylvania USA

Publisher

Wiley

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jia2.26126

Reference23 articles.

1. U.S. FDA.Press release: FDA approves first extended‐release injectable drug regimen for adults living with HIV.Washington DC:US FDA;2021.

2. ViiV.Press release: ViiV Healthcare announces first global regulatory approval of CABENUVA; the first complete long‐acting regimen for the treatment of HIV.Middlesex NJ:ViiV Healthcare;2020.

3. U.S. FDA.Cabenuva (cabotegravir extended‐release injectable suspension; rilpivirine extended‐release injectable suspension) co‐packaged for intramuscular use [package insert].Washington DC;2022.

4. The future of long-acting agents for preexposure prophylaxis

5. Advancing long-acting and extended delivery HIV prevention and treatment regimens through behavioural science: NIH workshop directions

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP